Works matching IS 2160763X AND DT 2024 AND VI 13 AND IP 7

Results: 13

Safety, Tolerability, and Pharmacokinetics of Single‐ and Multiple‐Ascending Doses of Sunobinop in Healthy Participants.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 7, p. 790, doi. 10.1002/cpdd.1394

By:

Cipriano, Alessandra;
Kapil, Ram P.;
Zhou, Mingyan;
Shet, Manjunath S.;
Whiteside, Garth T.;
Willsie, Sandra K.;
Harris, Stephen C.

Publication type:

Article

Effect of Strong CYP3A4 Inhibition, CYP3A4 Induction, and OATP1B1/3 Inhibition on the Pharmacokinetics of a Single Oral Dose of Sotorasib.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 7, p. 810, doi. 10.1002/cpdd.1392

By:

Cardona, Panli;
Dutta, Sandeep;
Houk, Brett

Publication type:

Article

A Population Pharmacokinetic Assessment of the Effect of Food on Selumetinib in Patients with Neurofibromatosis Type 1‐Related Plexiform Neurofibromas and Healthy Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 7, p. 770, doi. 10.1002/cpdd.1400

By:

Zuo, Peiying;
Arefayene, Million;
Pan, Wei‐Jian;
Freshwater, Tomoko;
Monteleone, Jonathan

Publication type:

Article

Nlmixr2 Versus NONMEM: An Evaluation of Maximum A Posteriori Bayesian Estimates Following External Evaluation of Gentamicin and Tobramycin Population Pharmacokinetic Models.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 7, p. 739, doi. 10.1002/cpdd.1395

By:

Duong, Alexandre;
Marsot, Amélie

Publication type:

Article

Pharmacokinetics, Safety, and Tolerability of Cedirogant in Healthy Japanese and Chinese Adults.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 7, p. 801, doi. 10.1002/cpdd.1386

By:

Mohamed, Mohamed‐Eslam F;
Qian, Yuli;
D'Cunha, Ronilda;
Hao, Shuai;
Carcereri De Prati, Roberto;
Levy, Gweneth F;
Hew, Kinjal;
Liu, Wei

Publication type:

Article

Concentration‐QTc Modeling of the DPP‐4 Inhibitor HSK7653 in a First‐in‐Human Study of Chinese Healthy Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 7, p. 716, doi. 10.1002/cpdd.1418

By:

Wang, Xiaoxu;
Liu, Hongzhong;
Cui, Cheng;
Niu, Xiaoye;
Li, Haiyan;
Niu, Shu;
Yan, Pangke;
Wu, Nan;
Li, Fangqiong;
Wu, Qinghe;
Chen, Kai;
Hu, Bei;
Liu, Dongyang

Publication type:

Article

Pharmacokinetics of Fipaxalparant, a Small‐Molecule Selective Negative Allosteric Modulator of Lysophosphatidic Acid Receptor 1, and the Effect of Food in Healthy Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 7, p. 819, doi. 10.1002/cpdd.1417

By:

Song, Yang;
Ali, Farah N.;
Ye, Zhan;
Zarzoso, Jennifer;
Rogowski, John;
Sun, Yajing;
Xin, Yan

Publication type:

Article

Effect of Hepatic and Renal Impairment on the Pharmacokinetics of Dersimelagon (MT‐7117), an Oral Melanocortin‐1 Receptor Agonist.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 7, p. 729, doi. 10.1002/cpdd.1413

By:

Ogasawara, Akihito;
Ide, Ryosuke;
Inoue, Shinsuke;
Teng, Renli;
Kawaguchi, Atsuhiro

Publication type:

Article

Evaluation of the Clinical Drug‐Drug Interaction Potential of Pritelivir on Transporters and CYP450 Enzymes Using a Cocktail Approach.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 7, p. 755, doi. 10.1002/cpdd.1408

By:

de Vries, Michiel;
Bonsmann, Susanne;
Pausch, Jörg;
Sumner, Melanie;
Birkmann, Alexander;
Zimmermann, Holger;
Kropeit, Dirk

Publication type:

Article

Safety, Tolerability, and Pharmacokinetics of Anaprazole, a Novel Proton Pump Inhibitor, in Healthy Chinese Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 7, p. 782, doi. 10.1002/cpdd.1405

By:

Wang, Fangfang;
Niu, Xiaoye;
Liu, Fei;
Ma, Xifeng;
Cheng, Fang;
Xu, Haiyan;
Wang, Li;
Xu, Yanjun;
Li, Haiyan

Publication type:

Article

Pharmacokinetics of Nitazoxanide Dry Suspensions After Single Oral Doses in Healthy Subjects: Food Effects Evaluation and Bioequivalence Study.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 7, p. 748, doi. 10.1002/cpdd.1402

By:

Zhang, Chenning;
Liang, Rui;
Liu, Dejie;
Wang, Xianghua;
Yang, Shuhua;
Hu, Qingwen;
Wen, Qing;
Zhao, Hengli

Publication type:

Article

Clinical Pharmacology of GP40321 (Insulin Glulisine Biosimilar): Pharmacokinetic and Pharmacodynamic Comparability in a Hyperinsulinemic‐Euglycemic Clamp Procedure.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 7, p. 828, doi. 10.1002/cpdd.1401

By:

Koksharova, Ekaterina;
Drai, Roman;
Noskov, Sergei;
Dorotenko, Artem;
Protsenko, Ekaterina;
Radaeva, Kseniia;
Arefeva, Anna;
Gefen, Maria;
Galstyan, Gagik;
Makarenko, Igor

Publication type:

Article

Issue Information.

Published in:: Clinical Pharmacology in Drug Development, 2024, v. 13, n. 7, p. 711, doi. 10.1002/cpdd.1120
Publication type:: Article